DE69611368T2 - Oligonukleotide spezifisch für humane papillomaviren - Google Patents
Oligonukleotide spezifisch für humane papillomavirenInfo
- Publication number
- DE69611368T2 DE69611368T2 DE69611368T DE69611368T DE69611368T2 DE 69611368 T2 DE69611368 T2 DE 69611368T2 DE 69611368 T DE69611368 T DE 69611368T DE 69611368 T DE69611368 T DE 69611368T DE 69611368 T2 DE69611368 T2 DE 69611368T2
- Authority
- DE
- Germany
- Prior art keywords
- papillomavires
- humane
- oligonucleotides specific
- oligonucleotides
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/471,974 US6509149B2 (en) | 1995-06-06 | 1995-06-06 | HPV-specific oligonucleotides |
| PCT/EP1996/002429 WO1996039501A2 (en) | 1995-06-06 | 1996-06-04 | Oligonucleotides specific for human papillomavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69611368D1 DE69611368D1 (de) | 2001-02-01 |
| DE69611368T2 true DE69611368T2 (de) | 2001-08-09 |
Family
ID=23873724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69611368T Expired - Lifetime DE69611368T2 (de) | 1995-06-06 | 1996-06-04 | Oligonukleotide spezifisch für humane papillomaviren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6509149B2 (de) |
| EP (1) | EP0832214B1 (de) |
| AR (1) | AR002758A1 (de) |
| AT (1) | ATE198352T1 (de) |
| AU (1) | AU6300296A (de) |
| CA (1) | CA2226457C (de) |
| DE (1) | DE69611368T2 (de) |
| WO (1) | WO1996039501A2 (de) |
| ZA (1) | ZA964447B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174870B1 (en) * | 1989-12-04 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of papillomavirus |
| US6084090A (en) * | 1997-09-05 | 2000-07-04 | The United States Of America As Represented By The Department Of Health And Human Services | Human papilloma virus anti-sense oligonucleotides |
| AT408446B (de) * | 1999-02-18 | 2001-11-26 | Altmann Friedrich Dr | Fucosyltransferase-gen |
| US20020155427A1 (en) | 2000-04-03 | 2002-10-24 | Cohenford Menashi A. | Detection and typing of human papillomavirus using PNA probes |
| US6936443B2 (en) | 2000-04-03 | 2005-08-30 | Cytyc Corporation | Detection and typing of human papillomavirus using PNA probes |
| AU2001257604A1 (en) * | 2000-04-11 | 2001-10-23 | Micrologix Biotech Inc. | HPV-specific short-mers |
| CA2440017A1 (en) * | 2001-05-03 | 2002-11-14 | Cornell Research Foundation, Inc. | Treatment of hpv caused diseases |
| WO2005030041A2 (en) * | 2003-09-25 | 2005-04-07 | Third Wave Technologies, Inc. | Detection of hpv |
| US8080643B2 (en) * | 2006-09-05 | 2011-12-20 | Third Wave Technologies, Inc. | HPV primers |
| US9376727B2 (en) | 2010-05-25 | 2016-06-28 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically truncated probes |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4661450A (en) * | 1983-05-03 | 1987-04-28 | Molecular Genetics Research And Development Limited Partnership | Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides |
| FR2629458B2 (fr) * | 1987-07-31 | 1991-08-09 | Ire Celltarg Sa | Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain |
| US5182377A (en) * | 1988-09-09 | 1993-01-26 | Hoffmann-La Roche Inc. | Probes for detection of human papillomavirus |
| US5194599A (en) * | 1988-09-23 | 1993-03-16 | Gilead Sciences, Inc. | Hydrogen phosphonodithioate compositions |
| US5264564A (en) * | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
| US5264562A (en) * | 1989-10-24 | 1993-11-23 | Gilead Sciences, Inc. | Oligonucleotide analogs with novel linkages |
| US5863717A (en) * | 1989-11-03 | 1999-01-26 | Abbott Laboratories | Use of conserved oligonucleotide primers to amplify human papillomavirus DNA sequences |
| CA2070664C (en) * | 1989-12-04 | 2000-08-08 | Christopher K. Mirabelli | Antisense oligonucleotide inhibition of papillomavirus |
| US5457189A (en) * | 1989-12-04 | 1995-10-10 | Isis Pharmaceuticals | Antisense oligonucleotide inhibition of papillomavirus |
| US5359051A (en) * | 1990-01-11 | 1994-10-25 | Isis Pharmaceuticals | Compounds useful in the synthesis of nucleic acids capable of cleaning RNA |
| NL9000134A (nl) * | 1990-01-19 | 1991-08-16 | Stichting Res Fonds Pathologie | Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr. |
| US5149797A (en) * | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| US5220007A (en) * | 1990-02-15 | 1993-06-15 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of RNA and production of encoded polypeptides |
| US5602240A (en) * | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| EP0491077A1 (de) | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten |
| FR2675803B1 (fr) | 1991-04-25 | 1996-09-06 | Genset Sa | Oligonucleotides fermes, antisens et sens et leurs applications. |
| FR2685346B1 (fr) | 1991-12-18 | 1994-02-11 | Cis Bio International | Procede de preparation d'arn double-brin, et ses applications. |
| EP0642589A4 (de) | 1992-05-11 | 1997-05-21 | Ribozyme Pharm Inc | Methode und reagenz zur inhibierung der viralen replikation. |
| US5272250A (en) * | 1992-07-10 | 1993-12-21 | Spielvogel Bernard F | Boronated phosphoramidate compounds |
| US5652355A (en) * | 1992-07-23 | 1997-07-29 | Worcester Foundation For Experimental Biology | Hybrid oligonucleotide phosphorothioates |
| US5593840A (en) * | 1993-01-27 | 1997-01-14 | Oncor, Inc. | Amplification of nucleic acid sequences |
| US5476925A (en) * | 1993-02-01 | 1995-12-19 | Northwestern University | Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups |
| AU7523794A (en) * | 1993-08-09 | 1995-02-28 | Isis Pharmaceuticals, Inc. | Oligomers for modulating viral processes |
| IL111660A (en) * | 1993-11-16 | 2005-05-17 | Genta Inc | Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them |
| US5550047A (en) * | 1994-02-18 | 1996-08-27 | University Of Massachusetts | Oligonucleotides with anti-Epstein-Barr virus activity |
| US5459243A (en) * | 1994-03-10 | 1995-10-17 | Isis Pharmaceuticals, Inc. | Apparatus and processes for the large scale generation and transfer of diazomethane |
| AU2584395A (en) | 1994-04-26 | 1995-11-16 | Genta Incorporated | Antisense oligomers for inhibiting human papillomaviruses |
| AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
-
1995
- 1995-06-06 US US08/471,974 patent/US6509149B2/en not_active Expired - Fee Related
-
1996
- 1996-05-30 ZA ZA964447A patent/ZA964447B/xx unknown
- 1996-06-04 EP EP96921927A patent/EP0832214B1/de not_active Expired - Lifetime
- 1996-06-04 WO PCT/EP1996/002429 patent/WO1996039501A2/en active IP Right Grant
- 1996-06-04 CA CA002226457A patent/CA2226457C/en not_active Expired - Fee Related
- 1996-06-04 AU AU63002/96A patent/AU6300296A/en not_active Abandoned
- 1996-06-04 AR ARP960102905A patent/AR002758A1/es unknown
- 1996-06-04 DE DE69611368T patent/DE69611368T2/de not_active Expired - Lifetime
- 1996-06-04 AT AT96921927T patent/ATE198352T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0832214B1 (de) | 2000-12-27 |
| US6509149B2 (en) | 2003-01-21 |
| WO1996039501A3 (en) | 1997-02-06 |
| US20020068820A1 (en) | 2002-06-06 |
| AU6300296A (en) | 1996-12-24 |
| ATE198352T1 (de) | 2001-01-15 |
| EP0832214A2 (de) | 1998-04-01 |
| CA2226457A1 (en) | 1996-12-12 |
| ZA964447B (en) | 1996-12-06 |
| DE69611368D1 (de) | 2001-02-01 |
| WO1996039501A2 (en) | 1996-12-12 |
| AR002758A1 (es) | 1998-04-29 |
| CA2226457C (en) | 2008-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO975731D0 (no) | Katalytisk DNA | |
| DE69520605D1 (de) | Verbesserte prallplatte für hufeisen | |
| FR2734058B1 (fr) | Amperemetre | |
| DE69602225D1 (de) | Tür für Haustiere | |
| DE59610887D1 (de) | Schalldämpfer | |
| DE69611368D1 (de) | Oligonukleotide spezifisch für humane papillomaviren | |
| DE69628084D1 (de) | Verteiler für Flüssigkeiten | |
| MA23595A1 (fr) | Oligonucleotides antisense | |
| DE69618194D1 (de) | Schalldämpfer | |
| DE69629196D1 (de) | Katalysatoranordnung | |
| DE29507696U1 (de) | Laufband für Haustiere | |
| DE29507884U1 (de) | Halter | |
| DE29509070U1 (de) | Selbsttränkebecken für Tiere | |
| DE29501186U1 (de) | Unterlage für Tiere | |
| DE29519475U1 (de) | Köderhaus für Nacktschnecken | |
| DE69626602D1 (de) | Vorrichtung für trickeffekte | |
| DE29503885U1 (de) | Pilker für Angelschnur | |
| DE29507882U1 (de) | Halter | |
| DE29510417U1 (de) | Stallanordnung | |
| DE29510419U1 (de) | Vorrichtung für Hufeisen | |
| DE29613689U1 (de) | Köderhaus für Nacktschnecken | |
| IT1280534B1 (it) | Richiamo per uccelli | |
| ATA121095A (de) | Legenest für hennen | |
| DE29500725U1 (de) | Katalysatorbauteil | |
| DE29604081U1 (de) | Abstandhalter für Dachrinnen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: HYBRIDON, INC., CAMBRIDGE, MASS., US |
|
| 8364 | No opposition during term of opposition |